Evidence map›Paper›PMID 34970203›Full record

ArticleFrontiers in neurology2021

Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials.

Hiroshi Kataoka, Masahiro Isogawa, Takashi Inoue, Miyoko Hasebe, Ryuzo Takashima, Shu Kasama, Hitoki Nanaura, Takao Kiriyama, Masato Kasahara, Kazuma Sugie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Role of zonisamide in advanced Parkinson's disease: a randomized placebo-controlled study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroshi KataokaDepartment of Neurology, Nara Medical University, Kashihara, Japan.
Masahiro IsogawaInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Takashi InoueInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Miyoko HasebeInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Ryuzo TakashimaInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Shu KasamaInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Hitoki NanauraDepartment of Neurology, Nara Medical University, Kashihara, Japan.
Takao KiriyamaDepartment of Neurology, Nara Medical University, Kashihara, Japan.
Masato KasaharaInstitute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Japan.
Kazuma SugieDepartment of Neurology, Nara Medical University, Kashihara, Japan.
Nara Medical University · JPNara Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialParkinsonREM sleep behavioral disorderssleepzonisamide

Identifiers

PMID34970203
PMCPMC8713296
OpenAlexW4200032709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.